tradingkey.logo
tradingkey.logo
검색

Embecta Corp

EMBC
관심 목록에 추가
3.350USD
-0.010-0.30%
종가 07/02, 13:00ET시세는 15분 지연됩니다
198.75M시가총액
1.75P/E TTM

자세한 내용은 Embecta Corp 회사

Embecta Corp. is a global medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. The Company has a portfolio of marketed products, including a variety of pen needles, syringes and safety injection devices. Its pen needles are sterile, single-use, medical devices, designed to be used in conjunction with pen injectors that inject insulin or other diabetes medications. It also sells safety pen needles, which have shields on both ends of the cannula that automatically deploy after the injection to help prevent needlestick exposure and injury during injection and disposal. Its traditional and safety pen needles are compatible and frequently used with pen injectors in the market. It sells sterile, single-use insulin syringes, which are used to inject insulin drawn from insulin vials. It also sells safety insulin syringes. It distributes its products through a variety of channels, including retail, hospitals and pharmacies.

Embecta Corp 정보

종목 코드 EMBC
회사 이름Embecta Corp
상장일Mar 21, 2022
CEOKurdikar (Devdatt)
직원 수1850
유형Ordinary Share
회계 연도 종료Mar 21
주소300 Kimball Drive
도시PARSIPPANY
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가United States of America
우편 번호07054
전화18624010000
웹사이트https://www.embecta.com/
종목 코드 EMBC
상장일Mar 21, 2022
CEOKurdikar (Devdatt)

Embecta Corp의 회사 임원진

이름
이름/직위
직위
주식 보유
변동
Mr. Devdatt (Dev) Kurdikar
Mr. Devdatt (Dev) Kurdikar
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
291.24K
+2.14%
Mr. Jacob (Jake) Elguicze
Mr. Jacob (Jake) Elguicze
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
114.14K
-2.21%
Mr. Jeffrey Z. (Jeff) Mann
Mr. Jeffrey Z. (Jeff) Mann
Senior Vice President, General Counsel, Product Development
Senior Vice President, General Counsel, Product Development
95.43K
-0.06%
Mr. Christopher R. (Chris) Reidy
Mr. Christopher R. (Chris) Reidy
Director
Director
55.24K
+41.35%
Mr. Robert J. (Bob) Hombach, CPA
Mr. Robert J. (Bob) Hombach, CPA
Independent Director
Independent Director
49.70K
+45.95%
Ms. Carrie L. Anderson
Ms. Carrie L. Anderson
Independent Director
Independent Director
49.70K
+45.96%
Dr. Milton Mayo Morris, Ph.D.
Dr. Milton Mayo Morris, Ph.D.
Independent Director
Independent Director
45.58K
+50.12%
Mr. Shaun Curtis
Mr. Shaun Curtis
Senior Vice President - Global Manufacturing, Supply Chain and Quality
Senior Vice President - Global Manufacturing, Supply Chain and Quality
34.01K
-18.45%
Ms. Jean Casner
Ms. Jean Casner
Chief Human Resources Officer, Senior Vice President
Chief Human Resources Officer, Senior Vice President
20.34K
-83.88%
Dr. Claire Pomeroy, M.D.
Dr. Claire Pomeroy, M.D.
Lead Independent Director
Lead Independent Director
--
--
더 보기
이름
이름/직위
직위
주식 보유
변동
Mr. Devdatt (Dev) Kurdikar
Mr. Devdatt (Dev) Kurdikar
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
291.24K
+2.14%
Mr. Jacob (Jake) Elguicze
Mr. Jacob (Jake) Elguicze
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
114.14K
-2.21%
Mr. Jeffrey Z. (Jeff) Mann
Mr. Jeffrey Z. (Jeff) Mann
Senior Vice President, General Counsel, Product Development
Senior Vice President, General Counsel, Product Development
95.43K
-0.06%
Mr. Christopher R. (Chris) Reidy
Mr. Christopher R. (Chris) Reidy
Director
Director
55.24K
+41.35%
Mr. Robert J. (Bob) Hombach, CPA
Mr. Robert J. (Bob) Hombach, CPA
Independent Director
Independent Director
49.70K
+45.95%
Ms. Carrie L. Anderson
Ms. Carrie L. Anderson
Independent Director
Independent Director
49.70K
+45.96%

자주 묻는 질문

Embecta Corp의 상위 5대 주주는 누구인가요?

Embecta Corp의 상위 5대 주주는 다음과 같습니다: Mr. Devdatt (Dev) Kurdikar

Embecta Corp(EMBC)의 주식을 보유한 기관은 몇 개입니까?

2026Q1 기준으로, Embecta Corp의 주식을 보유한 기관은 총 791곳이며, 이들이 보유한 주식의 총 가치는 약 59.40M로 전체 발행 주식의 100.13%를 차지합니다. 이는 2025Q4 대비 -4635325.00 증가한 수치입니다.

Embecta Corp의 최대 수익원은 무엇인가요?

2026Q1 기준, Embecta Corp의 Pen Needles 부문이 가장 높은 매출을 기록했으며, 금액은 185.50M로 전체 매출의 71.02%를 차지했습니다.